Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Recent study demonstrates prevention of serious vascular events with aspirin use in diabetes; however, participants also experienced major bleeding events.
It is well known that aspirin use is beneficial for patients who have cardiovascular disease, but it is less transparent for those who have not yet had a cardiovascular event. Patients with diabetes have a two-to-three-times greater risk of having a vascular event, compared to those without the disease. There have been previous studies to compare risk vs. benefit for patients taking a daily low-dose aspirin, but only a few have made comparisons in patients with diabetes. Researchers performed the ASCEND (A Study of Cardiovascular Events in Diabetes) randomized trial to examine the efficacy and safety of 100 mg aspirin, as compared with placebo, in patients with diabetes and without any cardiovascular events prior to trial entry.
http://www.diabetesincontrol.com/benefits-vs-risk-of-aspirin-use-in-diabetes/
It is well known that aspirin use is beneficial for patients who have cardiovascular disease, but it is less transparent for those who have not yet had a cardiovascular event. Patients with diabetes have a two-to-three-times greater risk of having a vascular event, compared to those without the disease. There have been previous studies to compare risk vs. benefit for patients taking a daily low-dose aspirin, but only a few have made comparisons in patients with diabetes. Researchers performed the ASCEND (A Study of Cardiovascular Events in Diabetes) randomized trial to examine the efficacy and safety of 100 mg aspirin, as compared with placebo, in patients with diabetes and without any cardiovascular events prior to trial entry.
http://www.diabetesincontrol.com/benefits-vs-risk-of-aspirin-use-in-diabetes/